European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended formA hearing on infringement of EP 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback